Cargando…
Cell Therapy for Parkinson’s Disease
In Parkinson’s disease (PD), dopamine neurons in the substantia nigra are degenerated and lost. Cell therapy for PD replaces the lost dopamine neurons by transplanting donor dopamine neural progenitor cells. Cell therapy for PD has been performed in the clinic since the 1980s and uses donor cells fr...
Autores principales: | MORIZANE, Asuka, TAKAHASHI, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791304/ https://www.ncbi.nlm.nih.gov/pubmed/26912295 http://dx.doi.org/10.2176/nmc.ra.2015-0303 |
Ejemplares similares
-
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease
por: Morizane, Asuka, et al.
Publicado: (2021) -
Cell therapy for Parkinson’s disease with induced pluripotent stem cells
por: Morizane, Asuka
Publicado: (2023) -
Exercise Promotes Neurite Extensions from Grafted Dopaminergic Neurons in the Direction of the Dorsolateral Striatum in Parkinson’s Disease Model Rats
por: Torikoshi, Sadaharu, et al.
Publicado: (2020) -
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
por: Doi, Daisuke, et al.
Publicado: (2020) -
Pretreatment with Perlecan-Conjugated Laminin-E8 Fragment Enhances Maturation of Grafted Dopaminergic Progenitors in Parkinson’s Disease Model
por: Adachi, Hiromasa, et al.
Publicado: (2022)